Pharmabiz

Shilpa Biologicals launches SB HiMax platform at CPHI Milan

Shilpa Biologicals, a subsidiary of Shilpa Medicare , launches its new gene to GMP manufacturing platform, SB HiMax which ...
Pharmabiz

Healthark sets agenda for next Generation of Life Sciences and HealthTech GCCs at RISE 2026

Healthark sets agenda for next Generation of Life Sciences and HealthTech GCCs at RISE 2026: Our Bureau, Mumbai Thursday, October 1, 2026, 11:30 Hrs [IST] Healthark, a healthcare ...
Pharmabiz

Takeda announces positive data from three phase 3 LATITUDE psoriasis studies of zasocitinib in adults with moderate-to-severe plaque psoriasis

Takeda announces positive data from three phase 3 LATITUDE psoriasis studies of zasocitinib in adults with moderate-to-severe plaque psoriasis: Osaka, Japan Thursday, October 1, 2 ...
Pharmabiz

Chugai Pharma to establish a subsidiary, Chugai Pharma Korea Co., Ltd in South Korea

Chugai Pharmaceutical Co., Ltd. announced that it has decided to establish a subsidiary, “Chugai Pharma Korea Co., Ltd.,” with the aim of obtaining marketing authorization for pharmaceutical products ...
Pharmabiz

US FDA accepts Roche’s NDA for fenebrutinib in both relapsing and primary progressive multiple sclerosis

US FDA accepts Roche’s NDA for fenebrutinib in both relapsing and primary progressive multiple sclerosis: Basel Thursday, October 1, 2026, 09:00 Hrs [IST] Roche announced that t ...
Pharmabiz

DGFT seeks pharma exporters inputs to expand TRACE list of export compliance charges towards boosting trade

DGFT seeks pharma exporters inputs to expand TRACE list of export compliance charges towards boosting trade: Shardul Nautiyal, Mumbai Thursday, October 1, 2026, 08:00 Hrs [IST] Th ...
Pharmabiz

Karnataka HC disposes petition by Viva Pharma, directs FSDA to follow due process before suspending drug license

Karnataka HC disposes petition by Viva Pharma, directs FSDA to follow due process before suspending drug license: Nandita Vijayasimha, Bengaluru Thursday, October 1, 2026, 08:00 H ...
Pharmabiz

Indian researchers work to drive future of precision oncology through patient-derived biology & AI: Expert

Indian researchers work to drive future of precision oncology through patient-derived biology & AI: Expert: Nandita Vijayasimha, Bengaluru Thursday, October 1, 2026, 08:00 Hrs [IS ...
Pharmabiz

DTAB recommends amendment to MDR to bring in clarity on fees paid for FSC

DTAB recommends amendment to MDR to bring in clarity on fees paid for FSC: Gireesh Babu, New Delhi Thursday, October 1, 2026, 08:00 Hrs [IST] The Drugs Technical Advisory Board (D ...
Pharmabiz

Pharma exports reports around 3.8% growth in August

Exports of drugs and pharmaceuticals from the country have reported a growth of around 3.8% in the month of August, 2026, at $2.606 million, as compared to $2.510 billion during the same month of last ...
Pharmabiz

Axplora launching “Axotecan” to strengthen global ADC supply

Axplora, a global manufacturing partner for small-molecule active pharmaceutical ingredients (APIs) and antibody-drug conjugates (ADCs), has completed the first R&D batches of Axotecan, its project to ...
Pharmabiz

Experts call for wider access to rabies monoclonal antibodies cocktail

Experts call for wider access to rabies monoclonal antibodies cocktail: Our Bureau, New Delhi Wednesday, September 30, 2026, 17:45 Hrs [IST] Experts have called for wider availabi ...